AMRX Operating Expenses

Amneal Pharmaceuticals Inc Class A · Operating Expenses

AMRX logo

AMRX Operating Expenses

Latest reported$822.55M
AMRX TTM Operating Expenses ($280.12M → $822.55M)
High-resolution chart · PNG

AMRX operating expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Amneal Pharmaceuticals Inc Class A Operating Expenses — Trailing twelve months (TTM) (USD)
Period endingOperating Expenses (USD)
822,550,000
808,903,000
787,204,000
791,596,000
698,254,000
677,850,000
771,112,000
795,320,000
771,454,000
756,914,000
651,845,000
619,913,000
612,907,000
872,107,000
879,636,000
855,507,000
875,626,000
621,868,000
616,257,000
607,924,000
569,078,000
557,185,000
537,238,000
523,713,000
497,071,000
481,393,000
498,145,000
496,546,000
517,513,000
507,090,000
438,536,000
379,958,000
329,939,000
301,602,000
280,120,000
307,722,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.